Laparoscopic rectal surgery has demonstrated its superiority over the open approach, however it still has some technical limitations that lead to the development of robotic platforms. Nevertheless the literature on this topic is rapidly expanding there is still no consensus about benefits of robotic rectal cancer surgery over the laparoscopic one. For this reason a review of all the literature examining robotic surgery for rectal cancer was performed. Two reviewers independently conducted a search of electronic databases (PubMed and EMBASE) using the key words "rectum", "rectal", "cancer", "laparoscopy", "robot". After the initial screen of 266 articles, 43 papers were selected for review. A total of 3013 patients were included in the review. The most commonly performed intervention was low anterior resection (1450 patients, 48.1%), followed by anterior resections (997 patients, 33%), ultra-low anterior resections (393 patients, 13%) and abdominoperineal resections (173 patients, 5.7%). Robotic rectal surgery seems to offer potential advantages especially in low anterior resections with lower conversions rates and better preservation of the autonomic function. Quality of mesorectum and status of and circumferential resection margins are similar to those obtained with conventional laparoscopy even if robotic rectal surgery is undoubtedly associated with longer operative times. This review demonstrated that robotic rectal surgery is both safe and feasible but there is no evidence of its superiority over laparoscopy in terms of postoperative, clinical outcomes and incidence of complications. In conclusion robotic rectal surgery seems to overcome some of Submit a Manuscript:
Abstract
Laparoscopic rectal surgery has demonstrated its superiority over the open approach, however it still has some technical limitations that lead to the development of robotic platforms. Nevertheless the literature on this topic is rapidly expanding there is still no consensus about benefits of robotic rectal cancer surgery over the laparoscopic one. For this reason a review of all the literature examining robotic surgery for rectal cancer was performed. Two reviewers independently conducted a search of electronic databases (PubMed and EMBASE) using the key words "rectum", "rectal", "cancer", "laparoscopy", "robot". After the initial screen of 266 articles, 43 papers were selected for review. A total of 3013 patients were included in the review. The most commonly performed intervention was low anterior resection (1450 patients, 48.1%), followed by anterior resections (997 patients, 33%), ultra-low anterior resections (393 patients, 13%) and abdominoperineal resections (173 patients, 5.7%). Robotic rectal surgery seems to offer potential advantages especially in low anterior resections with lower conversions rates and better preservation of the autonomic function. Quality of mesorectum and status of and circumferential resection margins are similar to those obtained with conventional laparoscopy even if robotic rectal surgery is undoubtedly associated with longer operative times. This review demonstrated that robotic rectal surgery is both safe and feasible but there is no evidence of its superiority over laparoscopy in terms of postoperative, clinical outcomes and incidence of complications. In conclusion robotic rectal surgery seems to overcome some of
INTRODUCTION
Laparoscopic colorectal surgery has progressively expanded since a number of randomized controlled trials (RCTs) [1] [2] [3] , review articles [4, 5] , meta-analysis [6] and case series [7] have demonstrated its better postoperative outcomes when compared to open surgery. However, laparoscopic surgery has some technical limitations such as poor ergonomics, 2-dimension view, coning and fulcrum effect, that may influence surgery in narrow anatomical fields such as in the pelvis during rectal surgery. The need to overcome these limitations leads to the development of robotic platforms. The da Vinci robotic surgical system is the only totally robotic platform available. After approval by Food and Drug Administration in 2000, its use progressively spreaded as demonstrated by the increasing number of publications. Three-D high definition vision, wristlike movement of instruments (endowrist TM ), stable camera holding, motion filter for tremor-free surgery and improved ergonomics for the surgeon are the advantages of the robotic system that may make rectal surgery more affordable and theoretically should provide better outcomes for the patient. Although the positive feedback is by the surgeons, there is still no evidence in literature about the superiority of robotic rectal surgery when compared to traditional laparoscopy. The aim of this study was to review the rapidly expanding literature in order to focus on the current state and assess any benefits of robotic rectal cancer surgery.
RESEARCH AND LITERATURE
A review of the literature examining robotic surgery for rectal cancer during the period from 2000 to 2015 was performed. Two reviewers independently conducted a search of electronic databases (PubMed and EMBASE) using the key words "rectum", "rectal", "cancer", "laparoscopy", "robot". The reference lists provided by the identified articles were additionally hand-searched to prevent article loss by the search strategy. This method of cross-references was continued until no further relevant publications were identified. The last search was performed on December 2015. Inclusion criteria were prospective, retrospective, randomized, comparative studies about robotic rectal surgery for cancer including anterior resections, low anterior resections, ultralow anterior resections, abdominoperineal resections, proctectomies, proctocolectomies. Exclusion criteria were: Abstracts, letters, editorials, technical notes, expert opinions, reviews, meta-analysis, studies reporting benign pathologies, studies in which the outcomes and parameters of patients were not clearly reported, studies in which it was not possible to extract the appropriate data from the published results, overlap between authors and centers in the published literature, non-English language papers.
The literature search yielded 266 papers, the process is listed in Figure 1 . After the 1 st filtering, the remaining 60 studies were 33 comparative, 26 case series, and 1 RCT. Then 17 studies were excluded due to duplicated data. They were 7 comparative and 9 case series. After this process a total of 43 papers, 27 comparative including only 1 RCT and 16 case series were included and reviewed. 
STUDIES OVERVIEW

Surgical technique
A total of 3013 robotic operations were performed. Sixteen studies [10, 12, 14, 16, 17, 22, 23, 25, 27, 28, 37, 38, [40] [41] [42] 48] (1257 patients) reported a totally robotic procedure which was carried out with either a single [10, 16, 17, 22, 23, 25, 27, 28, 37, 38, [40] [41] [42] 48] or a double docking [12, 28] hybrid robotic technique was performed: The inferior mesenteric vessels ligation and splenic flexure mobilization were performed laparoscopically whereas pelvic dissection and total mesorectal excision were performed robotically. In 5 studies [9, 11, 19, 29, 35] (372 patients) the robotic technique was not specified. Laparoscopic procedures described in the 27 comparative studies were performed in the same manner as robotic surgery using laparoscopic instruments (Table 1) .
Demographics and preoperative data
Most of patients were male (1911, 63%), the mean age was 58, the mean BMI was 26.6. Nine hundredeight patients (20%) underwent a neoadjuvant chemotherapy, 71 (2.3%) a neoadjuvant chemo-radiotherapy and 8 (0.2%) radiotherapy only. With regard to the type of operation, 1450 (48.1%) were low anterior resections, 997 (33%) were anterior resections (AR), 393 (13%) ultra-low anterior resections (ULAR) and 173 (5.7%) abdominoperineal resections (APR).
In the studies where the type of operation was not specified and where it was stated that a TME was performed [27, 29, 41] we assumed that all operations were low anterior resections (LAR) ( Table 2 )
Operative data
The mean robotic operative time ranged from 202 min [31] to 485.8 min [17] . For the 1345 laparoscopic patients in the selected comparative studies the mean operative time ranged from 158.1 [30] to 374.3 min [17] . This difference was statistically significant in 12 comparative studies [10, 14, [17] [18] [19] [20] [21] [22] [23] [24] 27, 28, 30] with a longer time for robotic surgery. Levic et al [9] were the only authors that reported a longer laparoscopic operative time (P = 0.055), but all interventions were performed with a single port technique (Table 3) . The estimated blood loss (EBL) was not reported in 14 studies. The mean value ranged from 17 mL [36] to 280 mL [14] with the robotic approach and from 59.2 [18] to 271.4 [15] in the laparoscopic group. Among 16 comparative studies [8] [9] [10] [12] [13] [14] [15] 17, [19] [20] [21] 23, 24, 29, 31, 33] that evaluated the EBL only Kang et al [23] and Erguner et al [21] reported a significantly lower EBL with the robotic approach when compared to the laparoscopic one. Thirty seven studies reported the conversion rate to open surgery. Three [8, 22, 31] out of 22 comparative studies [8] [9] [10] [11] [12] [13] [14] [15] 17, [19] [20] [21] [22] [23] [24] [25] [28] [29] [30] [31] [32] [33] showed a significantly lower conversion rate in the robotic series when compared to laparoscopy. The difference in overall conversion rate reported by Ielpo et al [14] was not statistically significant.
However, when data were analyzed according to the tumor location (upper, mid, lower rectum), the conversion rates between robotic and laparoscopic procedures for lower rectal cancers were respectively 1.8% and 9.2% (P = 0.04).
The rate of patients that underwent a protective ileostomy creation ranged from 0% [30] to 100% [10] both in the robotic and laparoscopic group. The difference in protective ileostomy creation was statistically significant in 5 studies. Kuo et al [17] reported a lower rate in the robotic vs the laparoscopic group whereas Saklani et al [19] , Erguner et al [21] , Kim et al [25] , Baek et al [29] showed a lower rate in the laparoscopic vs the robotic group.
Postoperative data
The mean postoperative day to first flatus ranged from 1.9 [48] to 3.2 [30] d in the robotic cases and from 2.4 [23] to 3.4 [17] in the laparoscopic ones. No statistically significant difference between robotic and laparoscopic cases was reported in any of the articles reviewed (Table  4) . The day of first postoperative liquid diet was available in 11 studies [6, 22, 27, 29, 34, 36, 43, 45, 47, 48, 50] ranging from 1 [16] to 3.9 [45] d in the robotic cases. Only two [22, 29] comparative studies reported the first postoperative liquid diet in their robotic and laparoscopic series, in one [22] of these the difference was statistically significant in favour of robotic surgery (3 d vs 5 d, P = 0.005).
The day of first postoperative solid diet was available in 11 studies [8, 10, 13, 17, 19, [23] [24] [25] 30, 34, 37] ranging from 2.58 [10] to 7.5 [18] d in the robotic cases and from 2.48 [10] to 7.7 [18] d in laparoscopic cases. Among 9 comparative studies [8, 10, 13, 17, 19, [23] [24] [25] 30] only Kang et al [23] reported a significant earlier oral intake in the robotic group (4.5 d vs 5.2 d. P = 0.004) when compared to the laparoscopic one.
The mean length of hospital stay ranged from 4.5 [33] to 14.2 [17] and from 3.6 [33] to 15.1 [17] d after robotic and laparoscopic surgery respectively. Among 8 comparative studies, Tam et al [15] , Levic et al [9] and Park et al [30] reported a shorter length of stay in their laparoscopic series whereas 5 [8, [22] [23] [24] 32] studies reported a significant shorter length of stay after robotic surgery.
No statistically significant differences in the overall 30 d mortality between the robotic and laparoscopic approach was found among 15 comparative studies [8] [9] [10] [11] 13, 14, [19] [20] [21] [22] [23] [24] [29] [30] [31] (0.10% and 0.45% respectively).
Twenty-three studies reported the reintervention rate. In the robotic series it ranged from 0% [8, 22, 32, 33, 42, 48] to 15% [20] whereas it ranged from 0% [32, 33] to 15.7% [11] after laparoscopic surgery. The most common cause of reintervention was anastomotic leak in both the robotic and laparoscopic groups. No statistically significant differences were found in any of the 12 comparative studies [11] [12] [13] [14] [15] [20] [21] [22] [23] [24] 32, 33] . The overall complication rate in the robotic and laparoscopic groups was 24.5% and 27.7% respectively. No significant differences in this parameter were reported between the robotic and laparoscopic series [8] [9] [10] [11] [13] [14] [15] [19] [20] [21] [22] [23] [24] [25] [28] [29] [30] [31] [32] [33] . The most frequent complication in both the robotic and laparoscopic cases was anastomotic leak followed by bowel obstruction and urinary complications (Table 5 ). Thirteen studies [10, 18, 19, [22] [23] [24] 26, 31, 37, 38, 40, 44, 45] reported urinary and sexual dysfunction after rectal surgery, 9 of these were comparative. Park et al [18] reported an earlier and significant restoration of erectile function after robotic surgery when compared to the laparoscopic one. Kim et al [26] observed an earlier recover of urinary function after robotic intervention within six months from the operation (P = 0.001). After 6 mo the difference was no more statistically significant. Park et al [8] 2015 South Korea Comparative Hybrid DV 133 84 Levic et al [9] 2014 Denmark Comparative NS DV 56 36 Yoo et al [10] 2014
South Korea Comparative Tot rob NS 44 26 Koh et al [11] 2014
Singapore Comparative NS NS 19 19 Melich et al [12] 2014 Canada Comparative Tot rob DV 92 106 Barnajian et al [13] 2014
United States Comparative Hybrid DV-S 20 20 20 Ielpo et al [14] 2014 Spain Comparative Tot rob NS 56 87 Tam et al [15] 2014
United States Comparative Hybrid DV 21 21 Ghezzi et al [16] 2014
Brazil Comparative Tot rob DV-S 65 109 Kuo et al [17] 2014
Taiwan Comparative Tot rob DV 36 28 Park et al [18] 2014
South Korea Comparative Hybrid DV 32 32 Saklani et al [19] 2013
South Korea Comparative NS NS 74 64 Fernandez et al [20] 2013
United States Comparative Hybrid DV-S 13 59 Erguner et al [21] 2013
Turkey Comparative Hybrid NS 27 37 D'Annibale et al [22] 2013
Italy Comparative Tot rob DV-S 50 50 Kang et al [23] 2013
South Korea Comparative Tot rob NS 165 165 165 Park et al [24] 2013
South Korea Comparative Hybrid DV 40 40 Kim et al [25] 2012
South Korea Comparative Tot rob DV 62 147 Kim et al [26] 2012
South Korea Comparative Hybrid DV 30 39 Bertani et al [27] 2011
Italy Comparative Tot rob DV 52 34 Kwak et al [28] 2011
South Korea Comparative Tot rob DV 59 59 Baek et al [29] 2011
United States Comparative NS NS 41 41 Park et al [30] 2011
South Korea Comparative Hybrid DV 52 123 88 Patriti et al [31] 2009
Italy Comparative Hybrid DV 29 37 Baik et al [32] 2008
South Korea Comparative Hybrid DV 18 18 Pigazzi et al [33] 2006
United States Comparative Hybrid DV 6 6 Parisi et al [34] 2014
Italy Case series Hybrid DV Si 40 Baek et al [35] 2014
South Korea Case series NS NS 182 Shiomi et al [36] 2014 Japan Case series Hybrid DV 113 Kim et al [37] 2014
South Korea Case series Tot rob DV-S 200 Stănciulea et al [38] 2013 Romania Case series Tot rob DV-Si 100 Zawadzki et al [39] 2013
United States Case series Hybrid DV 77 Sng et al [40] 2013
South Korea Case series Tot rob DV-S 197 Du et al [41] 2013
China Case series Tot rob DV 22 Alimoglu et al [42] 2012
Turkey Case series Tot rob DV 7 Akmal et al [43] 2012
United States Case series Hybrid DV 80 Park et al [44] 2012
United States Case series Hybrid DV-S 30 Kang et al [45] 2011
South Korea Case series Hybrid DV 389 deSouza et al [46] 2010 United States Case series Hybrid DV 44 Pigazzi et al [47] 2010
United States Case series Hybrid DV 143 Choi et al [48] 2009
South Korea Case series Tot rob DV 50 Ng et al [49] 2009 Singapore Case series Hybrid DV 8 Hellan et al [50] 2007
United States Case series Hybrid DV 39
Table 1 Studies overview
Tot rob: Totally Robotic; DV: Da Vinci; NS: Not specified.
complications in both groups (13.8% robotic vs 12.4% laparoscopic).
Oncological outcome
The mean number of harvested nodes ranged from 10 [14] to 20.6 [48] and from 9 [14] to 21 [10] in the robotic and laparoscopic cases respectively. Three of 22 comparatives [8] [9] [10] [11] [12] [13] [14] [15] 17, [19] [20] [21] [22] [23] [24] [25] [28] [29] [30] [31] [32] [33] studies reported a statistically significant difference in the number of harvested nodes between the robotic and laparoscopic approach: Levic et al [9] and D'Annibale et al [22] showed an higher number of examined nodes after robotic surgery whereas Yoo et al [10] showed an higher number of examined nodes after laparoscopic surgery (Table 7) . The mean length of distal resection margins after robotic rectal surgery was available in 20 studies [8] [9] [10] 13, [15] [16] [17] 19, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] 40, 41, 43, 45, 48, 50] . It ranged from 13.3 mm [10] to 460 mm [15] . Tumor involvement rate of distal margins was available 21 studies [8,9,11,12,15,17,20,21,23,25,26,28-30 ,34,36,37,39,46,48,50] and ranged from 0% [8, 15, 17, 20, 21, 25, 26, [28] [29] [30] 34, 36, 37, 48, 50] to 2.6% [39] of patients. An involvement of distal resection margin was found in 6 (0.47%) out of 1257 patients operated on with the robotic technique. The mean length of distal resection margins after laparoscopic rectal surgery was available in 19 [8] [9] [10] 13, 15, 17, 19, [21] [22] [23] [24] [25] [26] [28] [29] [30] [31] [32] [33] studies. It ranged from 13 mm [25] to 510 mm [15] . The involvement of distal margins was available in 14 studies [8, 9, 11, 12, 15, 17, 20, 21, 23, 25, 26, [28] [29] [30] and ranged from 0% [8, 9, 11, 12, 15, 21, 23, 25, 26, [28] [29] [30] to 5% [15] of patients. A distal margin positivity was reported in 3 (0.3%) out of 857 [20] 13/0 67. [40] 131/66 60 (20- [12] 92 RME [16] 65 RME Tot rob 299 (+ 58) 0 (0-175) [18] 32 RME Hybrid ---3 (9.4) 32 LME Tot lap ---3 (9.4) Saklani et al [19] 74 RME NS 365. [26] 30 RME Hybrid ----39 LME Tot lap ----Bertani et al [27] 52 RME [35] 182 RME NS ----Shiomi et al [36] 113 RME Hybrid 302 (135-683) 1 17 (0-690) 1 0 (0) -Kim et al [37] 200 RME Tot rob 308.3 -1 (0.5) 9 (4.5) Stănciulea et al [38] 100 RME Tot rob -150 (0-250) 1 4 (4) 64 (64) Zawadzki et al [39] 77 RME Hybrid 327 (178-510) [40] 197 RME Tot rob 278.7 (145-515) < 50 (50-1500) 1 0 (0) -Du et al [41] 22 RME Tot rob 220 (152-286) 33 (10-70) 0 (0) -Alimoglu et al [42] 7 RME Tot rob --0 (0) -Akmal et al [43] 80 RME Hybrid 303.5 -4 (5) 46 (57.5) Park et al [44] 30 RME [47] 143 RME Hybrid 297 (90-660) 283 (0-6000) 7 (4.9) 71 (50) Choi et al [48] 50 RME T Tot rob 304.8 (190-485) -0 (0) 16 (32) Ng et al [49] 8 RME Hybrid 278.7 (145-515) -0 (0) 6 (75) Hellan et al [50] 39 RME [12] 92 RME ---9.6 (8.3-11) -6 (6.5) 6 leak/abscess 106 LME ---9.9 (8.5-11.3) -5 (4.7) 4 leak/abscess, 1 obstruction due to adhesions Barnajian et al [13] 20 RME 3 (1-8) [14] 56 RME -- [15] 21 RME - [16] 65 RME 2 (1-2) [17] 36 RME 2.9 (1-6) -6.4 (4-12) 14.2 (9-27) --28 LME 3.4 (1-11) -5.8 (3-16) 15.1 (7-57) --Park et al [18] 32 RME - [19] 74 RME 2.45 (1-10) -4.6 (2-13) [20] 13 RME -- [21] 27 RME ----1 (3.7) 1 (3.7) Colonic necrosis 37 LME ----1 (2.7) 3 (8.1) 1 ileostomy retraction, 2 anastomotic leak D'Annibale et al [22] 50 RME -3 (3-5) [25] 62 RME --6 (+ 5) 12 (+ 6) --147 LME --7 (+ 5) 14 (+ 9) -- studies only Park et al [24] reported a longer distal margin in the robotic than in the laparoscopic group (P = 0.04). No significant difference in distal margins tumor involvement was reported when the robotic and laparoscopic approaches were compared. Mean circumferential resection margins (CRM) after robotic rectal surgery were reported in 9 studies [9, 13, 17, 21, 25, 30, 43, 44, 47] ranging from 1.8 mm [43] to 11 mm [44] . CRM tumor involvement was available in 32 studies [8, [10] [11] [12] [14] [15] [16] [17] 19, 20, [22] [23] [24] [25] [26] [27] [28] [29] [30] [35] [36] [37] 39, 40, 42, [44] [45] [46] [47] [48] [49] [50] and ranged from 0% [15, 16, 20, 22, 36, 42, 44, 46, 49, 50] to 11.1% [17] of patients with a 2.94 overall rate (76 out of 2583 patients). Mean CRM after laparoscopic rectal surgery were reported in 6 [9, 13, 17, 21, 25, 30] comparative studies. It ranged from 4 mm [21] to 8.2 mm [30] . CRM involvement was reported in 17 studies [8, [10] [11] [12] 14, 15, 17, 19, 20, [22] [23] [24] [25] [26] [28] [29] [30] and occurred in 51 out of 1158 patients (4.4%) Where the 2 procedures where compared only D'Annibale et al [22] observed a significantly greater number of patients with positive CRM in the laparoscopic series when compared with the robotic one. Only in 11 papers [9, 11, 13, 20, 21, 26, 32, 34, 36, 41, 44] reported the quality of mesorectum. Complete mesorectum excision ranged from 100% [11, 36] to 60% [9] in the robotic series and from 100% [11] to 40.6% [9] after laparoscopy. Total mesorectal excision was achieved in 83.62% of robotic cases vs 77.22% of laparoscopic ones. None of the 7 comparative studies showed a significant difference in the quality of mesorectum between the 2 procedures.
Park et al [24] 40 RME 2. [26] 30 RME ------39 LME ------Bertani et al [27] 52 RME 2 (1-5) 2 (1-13) -6 (4-51) 1 -2 (4) 34 OME 3 (1-9) 3 (2-12) -7 (4-24) 1 -0 (0) Kwak et al [28] 59 RME ------59 LME ------Baek et al [29] 41 RME -2.3 (1-13) -6.5 (2-33) 0 (0) -41 LME -2.4 (1-9) -6.6 (3-20) 0 (0) -Park et al [30] 52 RME 3. [31] 29 RME ---11.9 (6-29) 0 (0) --37 LME ---9.6 (5-37) 0 (0) --Baik et al [32] 18 RME 1. [33] 6 RME ---4.5 (3-11) -0 (0) 6 LME ---3.6 (3-6) -0 (0) Parisi et al [34] 40 RME 1 (1-3) [35] 182 RME -------Shiomi et al [36] 113 RME 2 (1-3) [37] 200 RME 2.4 -5 10.7 16 (8) ns Stănciulea et al [38] 100 RME ---10 (6-38) 1 -6 (6) 3 anastomotic leak, 1 bowel obstruction, 1 bleeding, 1 bowel injury Zawadzki et al [39] 77 RME ---6.4 (3-26) 0 (0) 3 (3.9) Anastomotic leak Sng et al [40] 197 RME ---9 (5-122) 1 --Du et al [41] 22 RME 2.6 (1.41-4.37) 1 --7.8 (7-13) 1 --Alimoglu et al [42] 7 RME ---8.1 (5-10) 1 0 (0) 0 (0) Akmal et al [43] 80 RME -2.75 (1-19) -7.55 (2-33) 0 (0) -Park et al [44] 30 RME ---4 (3-6) 1 0 (0) -Kang et al [45] 389 RME 2.3 3.9 -13.5 0 (0) 36 (9.2) ns deSouza et al [46] 44 RME ---5 (3-36) 1 1 (0.46) 2 (0.92) 1 anastomotic leak Pigazzi et al [47] 143 RME -2.7 (1-19) -8.3 (2-33) 0 (0) -Choi et al [48] 50 RME 1.9 (1-3) 2.6 (2-12) -9.2 (5-24) -0 (0) Ng et al [49] 8 RME ---5 (4-30) 1 0 (0) --Hellan et al [50] 39 RME -2 (1-11) Values are expressed as mean, solid diet includes soft diet. SBO: Small bowel obstruction; RME: Robotic mesorectal excision; LME: Laparoscopic mesorectal excision; OME: Open mesorectal excision; POD: Post operative day.
Short-term oncologic outcomes
Only 11 authors [8] [9] [10] 16, 19, 25, 28, 31, 38, 42, 47] reported short term oncologic outcomes (Table 8 ). The main drawback is the heterogeneity of the length of follow up ranging from 1 mo [9, 42] to 80 mo [ 8] making results difficult to compare.
The disease free survival in the laparoscopic group ranged from 75% [10] to 89.2% [31] with local recurrence ranging from 0% [9, 42] to 16.6% [8] and an overall survival ranging from 88.5% [10] to 98% [24] . The disease free survival in the robotic group ranged from 70.4% [16] to 100% [31, 42] with local recurrence ranging from 0% [9, 31, 42] to 12.8% [10] and an overall survival ranging from 85% [16] to 100% [42] .
CONCLUSION AND DISCUSSION
Robotic rectal surgery is constantly increasing over the years. Previous reviews have already demonstrated its safety and feasibility [51] [52] [53] , although there are not published studies demonstrating its superiority over the laparoscopic approach mainly due to the lack of randomized control trials. This lack of evidence about the effectiveness of robotic rectal surgery is in contrast with the overall opinion of surgeons that report an easier surgical approach especially to narrow and difficult anatomic spaces such as the pelvis. Several authors [52] [53] [54] reported 3D high definition vision, wrist-like movement Park et al [8] 133 RME 26 (19. [16] 65 RME 27 (41. [20] 13 RME 2 59 LME Erguner et al [21] 27 RME 3 (11. [22] 50 RME 5 (10) 5 (100) 50 LME 10 (20) 7 (70) 3 (30) Kang et al [23] 165 RME 34 (20. [24] 40 RME 6 (15) [32] 18 RME 4 (22.2) 3 (75) 1 (25) 18 LME 1 (5.5) 1 (100) Pigazzi et al [33] 6 RME 1 (16.6) 1 (100) 6 LME 1 (16.6) 1 (100) Parisi et al [34] 40 RME 4 (10) 1 (25) 1 (25) 2 (50) Shiomi et al [36] 113 RME 23 (20.3) 10 (43.5) 10 (43.5) 1 (4.3) 2 (8.7) Kim et al [37] 200 RME 16 (59.2) Stănciulea et al [38] 100 RME 18 (18) 10 (55.5) 2 (5.5) 6 (38.9) Zawadzki et al [39] 77 RME 2 3 Sng et al [40] 197 RME 74 (37) [41] 22 (4.5) RME 1 (4.5) 1 (100) 0 Alimoglu et al [42] 7 RME 2 (28.5) 2 (100) Kang et al [45] 389 RME 74 (19) 34 (45.9) 4 (5.4) 36 (48.6) deSouza et al [46] 44 RME 19 (43) 15 (79) [48] 50 RME 9 (18) 4 (44.4) 5 (55.5) Hellan et al [50] 39 RME 15 (38. Staderini F et al . Robotic rectal surgery RME: Robotic mesorectal excision; LME: Laparoscopic mesorectal excision; OME: Open mesorectal excision.
Ref. Pts Mesorectum DSF% (yr) LR (%) Distant metastases (%) OS % (yr) F-u mo (median)
Park et al [8] 133 RME 81.9 (5) [16] 65 RME 73.2 (5) [19] 74 RME 77.7 (3) Kim et al [25] 62 RME 0 (0) 3 (4.2) 98 (1.5) 17.4 147 LME 1 (0.7) 8 (5.4) 98 (1.7) 20.6 Kwak et al [28] 59 RME 1 (1.8) 2 (3.6) 17 (11-25) 59 LME 1 (1.9) 2 (3.7) 13 (9-22) Patriti et al [31] 29 RME 100 (3) 0 (0) 0 (0) 96.6 (2. Stănciulea et al [38] 100 RME 2 (2) 90 (3) 24 (9-63) Alimoglu et al [42] 7 RME 100 (1) 0 (0) 0 (0) 100 (1) 12 (6-21) 2 Pigazzi et al [47] 143 RME 77.6 (3) 2 (1.4) 13 (9) 97 (3) 17.4 (0.1-52.5)
2 Table 6 Short term oncologic outcomes 1 1 patient excluded (palliative ISR); 2 Mean. DSF: Disease free survival rate; LR: Local recurrence; OS: Overall survival; RME: Robotic mesorectal excision; LME: Laparoscopic mesorectal excision; OME: Open mesorectal excision. Park et al [8] 133 RME Levic et al [9] 56 RME 21 (7-83) Yoo et al [10] 44 RME 13.93 (+ 9. Koh et al [11] 19 RME 16 (4-24) [12] 92 RME 17. [13] 20 RME 14 (3-22) Ielpo et al [14] 56 RME 10 (0-29) -----2 (3.6) 0 (0) 14 (25) [16] 65 RME 20. Kuo et al [17] 36 RME
Ref. Pts Mesorectum
14 ( [18] 32 RME - Table 7 Histopathological data Saklani et al [19] 74 RME 11. Fernandez et al [20] 13 RME 16 [21] 27 RME 16 ( D'Annibale et al [22] 50 RME 16. [23] 165 RME 15 (+ 9. Kim et al [25] 62 RME Park et al [24] 40 RME 12.9 (+7. Kim et al [26] 30 RME -29 -27.9 (+ 10.2)
39 LME -37 -28.6 (+ 13.6)
Bertani et al [27] 52 RME 20.5 (5-43) [28] 59 RME 20 (12-27) [29] 41 RME 13. [30] 52 RME 19.4 (+ 10. Patriti et al [31] 29 RME 10. [32] 18 RME 20 ( Pigazzi et al [33] 6 RME 14 (9-28) - [34] 40 RME
19 ( Baek et al [35] 182 RME 14. [36] 113 RME 32 (11-112) Kim et al [37] 200 RME 16.1 -132.5 22 [38] 100 RME 14 (4-32) (24) 43 (43) 21 (21) 7 (7) Stănciulea et al [38] 77 RME 12. [40] 197 RME 16 (1-80) [41] 22 RME 14.3 (8-27) [42] 7 RME 16 (14-21) -----0 (0) 0 (0) 3 (42.8) 1 (14.2) 3 (42.8) 0 (0) Akmal et al [43] 80 RME 14. Park et al [44] 30 RME 20 (14-25) [45] 389 RME 15. [46] 44 RME 14 ( [47] 143 RME 14. (37) 0 (0) Choi et al [48] 50 RME 20.6 (6-48) - (20) 19 (38) 19 (38) 2 (4) Ng et al [49] 8 RME 15 (2-26)
0 Hellan et al [50] 39 RME 13 (7-28) Median. RME: Robotic mesorectal excision; LME: Laparoscopic mesorectal excision; OME: Open mesorectal excision.
of instruments (endowrist TM ), stable camera holding, motion filter for tremor-free surgery and improved ergonomics as major improvements in rectal surgery but it seems that these technical benefits have not reflected better clinical outcomes yet. This review aimed to analyze robotic rectal surgery from the first report to nowadays in order to focus on the current state and assess any benefits of robotic rectal surgery and its evolution through the years.
A well-established finding of this review is the longer operative time of robotic surgery when compared to the laparoscopic one. This is most likely due not to longer dissection but to non-surgical technical time. In fact in the totally robotic approach the docking and undocking has to be performed twice and in the hybrid approach there is the need to switch from laparoscopy to robot. A totally robotic technique without undocking is feasible, but this approach is technically much more difficult and as a consequence, a longer operative time is needed [10, 12, 14, 16, 17, [22] [23] [24] 27, 28, 37, 38, [40] [41] [42] 48] . Traditionally, longer operative time is related with increased morbidity, most likely related to the difficulty of the operation [53] . However prolonged times in robotic surgery are not associated with an increased complication rate as demonstrated by this review and previously published review and meta-analysis [55] . In our review 2 [21, 23] , out of 16 comparative studies reported a significantly lower estimated blood loss after robotic rectal surgery confirming that there is still no evidence that robotic rectal surgery for cancer may be associated with a lower intraoperative blood loss.
As regards convertion rates to open surgery, 3 [8, 22, 31] out of 22 comparative studies reported significant lower complication rates in robotic patients. Many authors associated these results to better visualization, 3D view, endowrist TM technology and stable camera holding resulting in an easier dissection in narrow anatomical fields such as the pelvis [56] . Even the results reported by Ielpo et al [14] suggest that the robotic approach has lower conversion rates when the tumor location requests a low anterior resection and as a consequence, when the operations is technically more challenging. Since converted cases are associated to greater morbidity and tumor recurrence [57] , robotic surgery could provide better oncologic long term results as well as a decreased perioperative morbidity.
The difference in protective ileostomy creation observed in this review can be related to several factors: The surgeon's habit, the tumor location, the surgeon's learning curve. Moreover, a trend toward an increasing stoma creation after robotic surgery could have been verified because of the initial worries about the new technique. On the bases of our findings the robotic approach seems associated with a higher rate of protective stoma creation.
One of the main benefits of minimally invasive surgery is the early recover. In this review we were unable to draw definitive results about any benefit of the robotic technique over conventional laparoscopy. Length of hospital stay, day of 1 st flatus, 1 st solid diet and 1 st liquid diet were substantially similar in both the robotic and laparoscopic series even if some authors reported some advantages for either the robotic or the laparoscopic technique [8, 9, 15, [22] [23] [24] 30, 32] . Anastomotic leak is the most severe surgical complication in rectal surgery. Well known risk factors for anastomotic leak are represented by cancers located less than 6 cm from anal verge, neoadjuvant radiochemotherapy, obesity and intraoperative blood transfusions [58] [59] [60] [61] [62] [63] . In this review the overall anastomotic leak rates in the robotic and laparoscopic series were similar (7.3% vs 7.6%) with no comparative study Park et al [8] 133 RME 81. [19] 74 RME 77.7 (3) [28] 59 RME 1 (1.8) 2 (3.6) 17 (11-25) 59 LME 1 (1.9) 2 (3.7) 13 (9-22) Patriti et al [31] 29 RME 100 ( [38] 100 RME 2 (2) 90 (3) 24 (9-63) Alimoglu et al [42] 7 RME 100 (1) 0 (0) 0 (0) 100 (1) 12 (6-21) 2 Pigazzi et al [47] 143 RME 77. reporting any significant difference between the 2 types of procedure. All together these results demonstrate that robotic surgery does not reduce the anastomotic leak rate. Nevertheless results of comparative studies are contradictory since 9 [11, 15, 19, [20] [21] [22] 23, 25, 30] of these reported less anastomotic leaks in the robotic group and 9 [8] [9] [10] 14, 17, 24, 28, 29, 31] in the laparoscopic one, but none of these results was significant. Looking at intraoperative complications, only Levic et al [9] reported a significant, higher rate in the robotic patients (4.48% vs 0%). However it must be considered that in this study there were more obese patients in the robotic group and all robotic and laparoscopic operations were performed in 2 different hospitals. The number of harvested and examined lymph nodes is pivotal in the postoperative tumor staging whose accuracy increases with the number of nodes retrieved within the surgical specimen. The robotic platform with its 3D high definition vision and wrist-like movement of instruments should improve the lymph nodes retrieving. Nevertheless, the difference between the mean harvested lymph nodes in the robotic and laparoscopic series was not substantial in our review (15.1 vs 15.7 respectively) and only 2 authors [9, 10] reported a significant higher number of retrieved lymph nodes in the robotic group.
The length of tumor involvement of both the distal and circumferential resection margins is considered an important parameter in evaluating the treatment of rectal cancer. Findings from the present review seems to determinate the lack of any advantages of robotic surgery over the laparoscopic approach. This issue might be explained by the likely surgeon's trend to prefer robotic approach in more advanced and distal tumors because of the theoretical superiority of this technique in pelvic dissection. In this review indeed 7 authors [10, 11, 15, 20, 22, 25, 31] reported a significant lower distance of the tumor from anal verge when the robotic approach was compared with the laparoscopic one. Two comparative studies [13, 22] reported even a significant wider CRM in their robotic series when compared to the laparoscopic ones. However a possible bias in the evaluation of this parameter is the non-uniform recording of data: some authors report median values, others the mean values making data not comparable. Even definition of circumferential resection margin is still not clear as it is currently considered as positive as positive if < 1 mm [8, 11, 14, 19, 24, 25, 30, 35, 64] by some authors and < 2 mm [10, 12, [15] [16] [17] 20, 22, 23, [26] [27] [28] [29] 36, 37, 39, 40, 42, [44] [45] [46] [47] [48] [49] [50] by others.
Thanks to its technical characteristics the robot platform should help in performing total and complete mesorectal excision that is an important target in rectal surgery since it potentially reflects the radicality of the operation. Unfortunately even if this is a major parameter in evaluating the radicality of the intervention, only 11 out of 43 studies in this review have addressed this important parameter. On the basis of our results any superiority of robotic mesorectal excision over the laparoscopic one cannot be demonstrated.
Robotic surgery may help in the identification and preservation of autonomic nerves due to high definition 3D image. Common sites of potential nerve damage are the superior hypogastric plexus, leading to ejaculation dysfunction in males and impaired lubrification in females, and the pelvic splanchnic nerve/pelvic plexus leading to erectile dysfunction in men. According to results of the CLASSIC trial [59] the risk of an autonomic injury with sexual dysfunction in males is significantly higher in laparoscopic surgery when compared to the open approach. The perceived advantages of robotic surgery may translate to decreased incidence of urinary dysfunction and erectile dysfunction in males. Although some preliminary results suggested that robotic assisted rectal surgery is superior to conventional laparoscopic surgery in preventing sexual or urinary dysfunction [63, 64] , we cannot provide definitive results since only few studies addressed this issue with high heterogeneity in the scores systems used for the analysis. Furthermore not all the patients in the studies agreed in answering questionnaires and this could lead to a possible type Ⅱ error. Some authors [26, 18] reported an earlier recovery of erectile, sexual desire and urinary function when the robotic group was compared with the laparoscopic one but they did not report any difference in long-term follow-up.
In conclusion, results from the present review show that robotic surgery is as feasible and safe as conventional laparoscopy in the treatment of rectal cancer, with the only drawback of longer operative time. The magnified view, the improved ergonomics and dexterity might improve the diffusion of minimally invasive approach in the treatment of rectal cancer. Potential clinical benefits of the robotic technique must be demonstrated, if any, only by RCTs.
